These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9370621)

  • 21. Misoprostol for post-partum haemorrhage in the Australian bush.
    Krishnan D; Ongso Y; Leknys M
    Aust Fam Physician; 2014 Aug; 43(8):569-70. PubMed ID: 25114997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of postpartum hemorrhage: options for home births in rural Ethiopia.
    Prata N; Gessessew A; Abraha AK; Holston M; Potts M
    Afr J Reprod Health; 2009 Jun; 13(2):87-95. PubMed ID: 20690252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing postpartum hemorrhage in Africa.
    Lazarus JV; Lalonde A
    Int J Gynaecol Obstet; 2005 Jan; 88(1):89-90. PubMed ID: 15617720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misoprostol in preventing postpartum hemorrhage: a meta-analysis.
    Langenbach C
    Int J Gynaecol Obstet; 2006 Jan; 92(1):10-8. PubMed ID: 16309682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial.
    Derman RJ; Kodkany BS; Goudar SS; Geller SE; Naik VA; Bellad MB; Patted SS; Patel A; Edlavitch SA; Hartwell T; Chakraborty H; Moss N
    Lancet; 2006 Oct; 368(9543):1248-53. PubMed ID: 17027730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Misoprostol Equivalent to Oxytocin for Postpartum Hemorrhage?
    Chireau MV
    Issues Law Med; 2015; 30(2):217-25. PubMed ID: 26710381
    [No Abstract]   [Full Text] [Related]  

  • 27. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana.
    Geller S; Carnahan L; Akosah E; Asare G; Agyemang R; Dickson R; Kapungu C; Owusu-Ansah L; Robinson N; Mensah-Homiah J
    BJOG; 2014 Feb; 121(3):319-25. PubMed ID: 24283350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of sublingual misoprostol as first-line treatment for primary post-partum hemorrhage: results of a multicenter trial.
    Okonofua FE; Ogu RN; Akuse JT; Ujah IA; Galadanci HS; Fabamwo AO
    J Obstet Gynaecol Res; 2014 Mar; 40(3):718-22. PubMed ID: 24320203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations for scale-up of community-based misoprostol distribution programs.
    Robinson N; Kapungu C; Carnahan L; Geller S
    Int J Gynaecol Obstet; 2014 Jun; 125(3):285-8. PubMed ID: 24680582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006.
    Lalonde A; Daviss BA; Acosta A; Herschderfer K
    Int J Gynaecol Obstet; 2006 Sep; 94(3):243-53. PubMed ID: 16842791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misoprostol for postpartum hemorrhage: moving from evidence to practice.
    Starrs A; Winikoff B
    Int J Gynaecol Obstet; 2012 Jan; 116(1):1-3. PubMed ID: 22078140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic misoprostol for the prevention of postpartum hemorrhage: a randomized controlled trial.
    Uncu Y; Karahasan M; Uyaniklar Ö; Uncu G
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):15-22. PubMed ID: 25635970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial.
    Widmer M; Blum J; Hofmeyr GJ; Carroli G; Abdel-Aleem H; Lumbiganon P; Nguyen TN; Wojdyla D; Thinkhamrop J; Singata M; Mignini LE; Abdel-Aleem MA; Tran ST; Winikoff B
    Lancet; 2010 May; 375(9728):1808-13. PubMed ID: 20494730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misoprostol for the management of postpartum haemorrhage.
    Elati A; Weeks A
    BMJ; 2011 May; 342():d2877. PubMed ID: 21571915
    [No Abstract]   [Full Text] [Related]  

  • 35. Community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: cost-effectiveness, mortality, and morbidity reduction analysis.
    Sutherland T; Meyer C; Bishai DM; Geller S; Miller S
    Int J Gynaecol Obstet; 2010 Mar; 108(3):289-94. PubMed ID: 20079493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tackling the unacceptable: Nigeria approves misoprostol for postpartum haemorrhage.
    Jadesimi A; Okonofua FE
    J Fam Plann Reprod Health Care; 2006 Oct; 32(4):213-4. PubMed ID: 17032506
    [No Abstract]   [Full Text] [Related]  

  • 37. Misoprostol for the prevention and treatment of postpartum haemorrhage.
    Hofmeyr GJ; Gülmezoglu AM
    Best Pract Res Clin Obstet Gynaecol; 2008 Dec; 22(6):1025-41. PubMed ID: 18786863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misoprostol to prevent and treat postpartum haemorrhage: a systematic review and meta-analysis of maternal deaths and dose-related effects.
    Hofmeyr GJ; Gülmezoglu AM; Novikova N; Linder V; Ferreira S; Piaggio G
    Bull World Health Organ; 2009 Sep; 87(9):666-77. PubMed ID: 19784446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of misoprostol in third stage of labour.
    Khan R; Sharma S
    Lancet; 2002 Feb; 359(9307):708-9; author reply 709-10. PubMed ID: 11879892
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of misoprostol in third stage of labour.
    Shannon C; Winikoff B
    Lancet; 2002 Feb; 359(9307):709; author reply 709-10. PubMed ID: 11879893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.